Preventing cardiovascular disease among Canadians: Is the treatment of hypertension or dyslipidemia cost-effective?

Por Grover, Steven, Coupal, Louis, Lowensteyn, Ilka
Publicado em 2008

Determining the cost-effectiveness of preventing cardiovascular disease: Are estimates calculated over the duration of a clinical trial adequate?

Por Grover, Steven A, Coupal, Louis, Lowensteyn, Ilka
Publicado em 2008

Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia?

Por Grover, Steven A, Coupal, Louis, Kaouache, Mohammed, Lowensteyn, Ilka
Publicado em 2007

Zowall and associates respond

Por Grover, Steven A., Zowall, Hanna, Coupal, Louis, Deutsch, Antal, Gilmore, Norbert
Publicado em 1993

Discussing Coronary Risk with Patients to Improve Blood Pressure Treatment: Secondary Results from the CHECK-UP Study

Por Grover, Steven A., Lowensteyn, Ilka, Joseph, Lawrence, Kaouache, Mohammed, Marchand, Sylvie, Coupal, Louis, Boudreau, Ghislain
Publicado em 2008

Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines

Por Grover, Steven A., Dorais, Marc, Paradis, Gilles, Fodor, J. George, Frohlich, Jiri J., McPherson, Ruth, Coupal, Louis, Zowall, Hanna
Publicado em 2000